Adding cetuximab to chemotherapy led to worse outcomes for patients with resectable liver metastases caused by colorectal cancer, updated data from the New EPOC trial showed.
[Cancer Management and Research] Use of inflammatory indices, particularly C-reactive protein/albumin ratio (CAR), is effective in predicting risk for postoperative complications in patients undergoing resection of colorectal cancer.
Patients older than 25 years have significantly higher rates of OS and RFS at 3 and 5 years compared with patients younger than 25.
Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.
These findings have implications for the screening of survivors of childhood or young adult-related cancers that are independent of prior abdominopelvic radiation therapy.